1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 9,040 | 9,300 | 30.09. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.09. | enVVeno Medical Corporation: enVVeno Medical CEO Rob Berman Goes Direct to Investors with New "WTF" Video Series | 364 | ACCESS Newswire | New CEO-led video series provides investors with straight talk, just the facts, with no B.S. or corporate spinReal answers to what investors need to know about enVVeno and why they need to know itWatch... ► Artikel lesen | |
| 11.09. | enVVeno Medical Corporation: enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-Demand | 308 | ACCESS Newswire | Access the video webcast here IRVINE, CA / ACCESS Newswire / September 11, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company"), today announced that its pre-recorded... ► Artikel lesen | |
| 27.08. | enVVeno Medical Corporation: enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference | 416 | ACCESS Newswire | Video Webcast Now Available Here IRVINE, CA / ACCESS Newswire / August 27, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company") today announced that Robert Berman, Chief... ► Artikel lesen | |
| 04.08. | enVVeno Medical Corporation: Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to Standard of Care Treatments | 447 | ACCESS Newswire | Published economic health study shows both short- and long-term cost-effectiveness of replacement venous value therapy versus standard-of-care treatments for deep venous CVI, generating compelling evidence... ► Artikel lesen | |
| 31.07. | enVVeno Medical wins FDA IDE for non-surgical transcatheter replacement venous valve | 1 | MassDevice | ||
| 31.07. | enVVeno Medical erhält FDA-Zulassung für zulassungsrelevante Studie | 2 | Investing.com Deutsch | ||
| 31.07. | enVVeno Medical GAAP EPS of -$5.37 misses by $2.10 | 2 | Seeking Alpha | ||
| ENVVENO MEDICAL Aktie jetzt für 0€ handeln | |||||
| 31.07. | enVVeno Medical Corporation: enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve | 502 | ACCESS Newswire | Company Enters the Second Half of 2026 With Tailwinds From an FDA IDE Approval, With the TAVVE Pivotal Study Expected to Begin Enrolling Patients During the Second Half of This Year and Cash Runway... ► Artikel lesen | |
| 30.07. | enVVeno Medical Corp - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 15.07. | enVVeno Medical Corporation: enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment | 468 | ACCESS Newswire | CEO Explains How Broad Patent Protection, Combined with First-Ever FDA IDE Approval, Positions enVVe to Own a Multi-Billion-Dollar Venous Disease MarketWatch the "What This Means" video here IRVINE... ► Artikel lesen | |
| 14.07. | enVVeno Medical Corp - 8-K, Current Report | - | SEC Filings | ||
| 07.07. | enVVeno Medical receives U.S. patent for venous valve system | 2 | Investing.com | ||
| 07.07. | enVVeno Medical Corporation: enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial | 800 | ACCESS Newswire | New Patent Broadly Protects Core Technology Behind Potential First Non-Surgical Replacement Venous Valve Builds on First-Ever FDA IDE Approval for Pivotal Study of enVVe System Targeting Multi-Billion-Dollar... ► Artikel lesen | |
| 22.06. | enVVeno Medical Corporation: enVVeno Medical to Present in the Webull Corporate Connect Webinar Series | 352 | ACCESS Newswire | - Live webcast on Wednesday, June 24th at 2:00 PM ET- Access the event here IRVINE, CA / ACCESS Newswire / June 22, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"),a company... ► Artikel lesen | |
| 02.06. | enVVeno Medical Corporation: enVVeno Medical to Participate in the Virtual Investor Closing Bell Series | 304 | ACCESS Newswire | Live video webcast with Robert Berman, Chief Executive Officer of enVVeno Medical, on Tuesday, June 9that 4:00 PM ETRegister here IRVINE, CA / ACCESS Newswire / June 2, 2026 / enVVeno Medical Corporation... ► Artikel lesen | |
| 12.05. | enVVeno Medical Corporation: enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment | 539 | ACCESS Newswire | First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-surgical Replacement Venous ValveIDE approval positions enVVeno to advance what could become the first effective treatment option for the... ► Artikel lesen | |
| 07.05. | enVVeno Medical GAAP EPS of -$5.89 | 3 | Seeking Alpha | ||
| 07.05. | enVVeno Medical Corporation: enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System | 800 | ACCESS Newswire | Company ended the first quarter with approximately $25 million in cash and investmentsCapital on hand should fund operations through multiple key milestones into Q3 2027Company recently received FDA... ► Artikel lesen | |
| 06.05. | enVVeno Medical Corp - 10-Q, Quarterly Report | - | SEC Filings | ||
| 29.04. | enVVeno receives FDA approval for venous valve pivotal trial | 2 | Investing.com |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 39,680 | +0,28 % | Fresenius Medical Care: China sorgt für eine Millionenbelastung | Fresenius Medical Care stellt sein Geschäft in China neu auf und nimmt dafür eine erhebliche Belastung in Kauf. Der Dialysekonzern rechnet im dritten Quartal 2026 mit Sonderaufwendungen von rund 110... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,610 | -0,95 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 31,200 | -0,26 % | 12 Prozent bessere Leistung, 14 Prozent weniger Belastung: Warum ZEISS das Brillenglas neu denkt - und wo Rise Nano Optics ins Spiel kommt | ||
| ECKERT & ZIEGLER | 12,330 | -3,22 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| INTUITIVE SURGICAL | 357,80 | -0,46 % | 1.156 Trades im Juli: Trumps Aktien-Deals: Millionenverkäufe bei zwei Tech-Giganten | © Foto: Julia Demaree Nikhinson - APIn Trumps Depot wurden im Juli 1.156 Transaktionen verzeichnet, darunter Verkäufe von Microsoft- und Amazon-Aktien für jeweils bis zu 25 Millionen US-Dollar sowie... ► Artikel lesen | |
| MEDTRONIC | 76,90 | +0,95 % | Dividendenbekanntmachungen (25.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADF GROUP INC CA00089N1033 0,02 CAD 0,0124 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,22 USD 0,1933 EUR ASMODEE GROUP AB SE0023615638 - 0... ► Artikel lesen | |
| GERRESHEIMER | 27,720 | -4,22 % | Quartalsbericht: Gerresheimer springt vor Zahlentermin an | Der Düsseldorfer Verpackungsspezialist legt an diesem Mittwoch finale Zahlen für das erste Quartal sowie vorläufige Ergebnisse für das zweite Quartal vor. Unter Anlegern wächst die Hoffnung, dass sich... ► Artikel lesen | |
| THERMO FISHER | 580,20 | -2,72 % | Thermo Fisher Scientific and Evosep Enter Reseller Agreement for Evosep Eno | Thermo Fisher Scientific to offer the Evosep Eno separation platform to customers, expanding access to standardized, high-throughput proteomics workflowsSINGAPORE, Sept. 28, 2026 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| TELADOC HEALTH | 5,130 | +0,23 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Legal Officer Transition | NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with... ► Artikel lesen | |
| STRATEC | 21,650 | -1,59 % | EQS-PVR: STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: STRATEC SE
STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| RHOEN-KLINIKUM | 14,500 | -1,36 % | Sichere Versorgung chronisch erkrankter Menschen: RHÖN-KLINIKUM Campus Bad Neustadt stärkt Patientensicherheit | 17. September ist Welttag der Patientensicherheit | Bad Neustadt a. d. Saale (ots) - Welttag der Patientensicherheit: Campus Bad Neustadt verbindet bewährte Standards, systematisches Risikomanagement und Lernen aus kritischen EreignissenAm 17. September... ► Artikel lesen | |
| M1 AESTHETICS | 13,000 | +1,56 % | Dividendenbekanntmachungen (08.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2 MILK COMPANY LIMITED NZATME0002S8 0,4135 NZD 0,2059 EUR AGRANA BETEILIGUNGS-AG AT000AGRANA3 - 0,35 EUR BANK OF CHONGQING CO LTD CNE100001QN2 0... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 74,14 | -0,64 % | Eurofins Scientific: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 7,740 | -5,15 % | Are Options Traders Betting on a Big Move in Alignment Healthcare Stock? | ||
| FRESENIUS | 43,800 | -2,12 % | Fresenius baut Kapazität in Europa für 54 Mio Euro aus | DJ Fresenius baut Kapazität in Europa für 54 Mio Euro aus
DOW JONES--Fresenius hat seine Kapazitäten für die Herstellung von Infusionslösungen in Polen und Italien erweitert. Wie der DAX-Konzern... ► Artikel lesen |
Das Unternehmen ENVVENO MEDICAL CORPORATION kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -9,170 (-100,00 %) liegt der Kurs bei 9,170 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENVVENO MEDICAL CORPORATION finden Sie auf Wallstreet Online.